Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: A prospective, comparative, observational study

被引:81
作者
Diav-Citrin, Orna [1 ,2 ]
Otcheretianski-Volodarsky, Anna [3 ]
Shechtman, Svetlana [1 ]
Ornoy, Asher [1 ,2 ]
机构
[1] Israel Minist Hlth, Israeli Teratol Informat Serv, IL-9446724 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel
[3] Hebrew Univ Jerusalem, Div Clin Pharm, IL-91905 Jerusalem, Israel
关键词
Anti-TNF-alpha; Infliximab; Etanercept; Adalimumab; Autoimmune diseases; Pregnancy; Congenital anomalies; INFLAMMATORY-BOWEL-DISEASE; NECROSIS-FACTOR ANTAGONISTS; RHEUMATOID-ARTHRITIS; SAFETY ASSESSMENT; CROHNS-DISEASE; INFLIXIMAB USE; WOMEN; ASSOCIATION; MEDICATIONS; ETANERCEPT;
D O I
10.1016/j.reprotox.2013.11.004
中图分类号
Q [生物科学];
学科分类号
090105 [作物生产系统与生态工程];
摘要
Objective: To evaluate pregnancy safety of anti-TNF-alpha medications. Design: Prospective, comparative, observational study done at the Israeli Teratology Information Service between 2002 and 2011. Results: 83 anti-TNF-alpha-exposed-pregnancies (97.6% in the first trimester, T1) were followed-up and compared with 86 disease-matched (DM) and 341 non-teratogenic-exposed (NTE) pregnancies. The anti-TNF-alpha group consisted of 35 infliximab-, 25 etanercept-, and 23 adalimumab-exposed pregnancies. The rate of major congenital anomalies did not significantly differ between the three groups [3/65 (4.6%) (anti-TNF-alpha, T1), 5/79(6.3%) (DM), 8/336(2.4%) (NTE)1, even after excluding genetic or cytogenetic anomalies 13/65 (4.6%) (anti-TNF-alpha, T1), 4/79 (5.1%) (DM), 6/336 (1.8%) (NTE)]. There were no cases of VATER/VACTERL association. Conclusion: The present study suggests that anti-TNF-alpha treatment does not pose a major teratogenic risk in humans. This conclusion is based on relatively small numbers of exposed pregnancies and should be interpreted with caution. Larger studies are needed to establish anti-TNF-alpha pregnancy safety. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:78 / 84
页数:7
相关论文
共 36 条
[1]
Exposition to anti-TNF drugs during pregnancy: Outcome of 15 cases and review of the literature [J].
Berthelot, Jean-Marie ;
De Bandt, Michel ;
Goupille, Philippe ;
Solau-Gervais, Elisabeth ;
Liote, Frederic ;
Goeb, Vincent ;
Azais, Isabelle ;
Martin, Antoine ;
Pallot-Prades, Beatrice ;
Maugars, Yves ;
Mariette, Xavier .
JOINT BONE SPINE, 2009, 76 (01) :28-34
[2]
Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006 [J].
Bortoli, A. ;
Pedersen, N. ;
Duricova, D. ;
D'Inca, R. ;
Gionchetti, P. ;
Panelli, M. R. ;
Ardizzone, S. ;
Sanroman, A. L. ;
Gisbert, J. P. ;
Arena, I. ;
Riegler, G. ;
Marrollo, M. ;
Valpiani, D. ;
Corbellini, A. ;
Segato, S. ;
Castiglione, F. ;
Munkholm, P. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (07) :724-734
[3]
Bowden AP, 2001, J RHEUMATOL, V28, P355
[4]
Carter JD, 2006, J RHEUMATOL, V33, P1014
[5]
A Safety Assessment of Tumor Necrosis Factor Antagonists During Pregnancy: A Review of the Food and Drug Administration Database [J].
Carter, John D. ;
Ladhani, Anil ;
Ricca, Louis R. ;
Valeriano, Joanne ;
Vasey, Frank B. .
JOURNAL OF RHEUMATOLOGY, 2009, 36 (03) :635-641
[6]
Chambers CD, 2012, BIRTH DEFECTS RES A, V94, P325
[7]
Chambers CD, 2004, ARTHRITIS RHEUM, V50, pS479
[8]
Emerging data on the use of anti-tumor necrosis factor-alpha medications in pregnancy [J].
Chambers, Christina D. ;
Johnson, Diana L. .
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2012, 94 (08) :607-611
[9]
A meta-analysis on the influence of inflammatory bowel disease on pregnancy [J].
Cornish, J. ;
Tan, E. ;
Teare, J. ;
Teoh, T. G. ;
Rai, R. ;
Clark, S. K. ;
Tekkis, P. P. .
GUT, 2007, 56 (06) :830-837
[10]
Association of Higher Rheumatoid Arthritis Disease Activity During Pregnancy With Lower Birth Weight Results of a National Prospective Study [J].
de Man, Yael A. ;
Hazes, Johanna M. W. ;
van der Heide, Hugo ;
Willemsen, Sten P. ;
de Groot, Christianne J. M. ;
Steegers, Eric A. P. ;
Dolhain, Radboud J. E. M. .
ARTHRITIS AND RHEUMATISM, 2009, 60 (11) :3196-3206